ClinicalTrials.Veeva

Menu
W

West Houston Area Clinical Trial Consultants | Wichita, KS

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Empagliflozin
BI 690517
Obicetrapib
Vicadrostat

Parent organization

This site is a part of West Houston Area Clinical Trial Consultants

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 4 total trials
Status recently updated

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People ca...

Not yet enrolling
Enrolling
Heart Failure
Drug: Placebo matching vicadrostat
Drug: Empagliflozin

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left...

Enrolling
Heart Failure
Drug: vicadrostat
Drug: Empagliflozin

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval m...

Enrolling
Hypertension
Hypertension, Essential
Device: Medtronic Astra/Azure DR MRI IPG with AVIM therapy Deactivated
Device: Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Obicetrapib
Drug: Placebo

Trial sponsors

Boehringer Ingelheim logo
N
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems